RFL 1.95 (+8.33%)
US75062E1064BiotechnologyBiotechnology

Rafael Holdings (RFL) Stock Highlights

1.95 | +8.33%
2024-12-21 07:16:13
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.

Statistics

Range Today
1.72 1.95
Volume Today 74.2K
Range 1 Year
1.29 2.5
Volume 1 Year 7.15M
Range 3 Year
1.29 5.44
Volume 3 Year 52.75M
Range 10 Year
1.29 66.44
Volume 10 Year 152.94M

Highlights

Market Capitalization 57.99M (small)
Floating Shares 18.97M
Current Price 1.95
Price To Earnings -1.05
Price To Revenue 77.79
Price To Book 0.58
Earnings Per Share -1.67
Payout Ratio 0%

Performance

Latest +8.33%
1 Month +1.56%
3 Months +12.07%
6 Months +36.36%
1 Year +7.73%
3 Years -62.14%
5 Years -88.96%
10 Years -36.07%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.